SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B4 - Prospectus [Rule 424(b)(4)]:
SEC Accession No. 0001193125-19-288440
Filing Date
2019-11-08
Accepted
2019-11-08 16:41:21
Documents
15

Document Format Files

Seq Description Document Type Size
1 424B4 d692555d424b4.htm 424B4 1975572
2 GRAPHIC g692555g11p21.jpg GRAPHIC 71648
3 GRAPHIC g692555g22s53.jpg GRAPHIC 85871
4 GRAPHIC g692555g33a61.jpg GRAPHIC 34226
5 GRAPHIC g692555g39g35.jpg GRAPHIC 74888
6 GRAPHIC g692555g40t78.jpg GRAPHIC 119642
7 GRAPHIC g692555g47r61.jpg GRAPHIC 127435
8 GRAPHIC g692555g51n59.jpg GRAPHIC 108910
9 GRAPHIC g692555g62p22.jpg GRAPHIC 149377
10 GRAPHIC g692555g66k92.jpg GRAPHIC 91976
11 GRAPHIC g692555g68y82.jpg GRAPHIC 97208
12 GRAPHIC g692555g73n23.jpg GRAPHIC 64015
13 GRAPHIC g692555g75k63.jpg GRAPHIC 74333
14 GRAPHIC g692555g77w99.jpg GRAPHIC 135383
15 GRAPHIC g692555g90r10.jpg GRAPHIC 52156
  Complete submission text file 0001193125-19-288440.txt   3751556
Mailing Address 101 LINDENWOOD DRIVE SUITE 405 MALVERN PA 19355
Business Address 101 LINDENWOOD DRIVE SUITE 405 MALVERN PA 19355 610-725-1500
Galera Therapeutics, Inc. (Filer) CIK: 0001563577 (see all company filings)

IRS No.: 461454898 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B4 | Act: 33 | File No.: 333-234184 | Film No.: 191204596
SIC: 2834 Pharmaceutical Preparations